Bruker Launches the S2 POLAR™ High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry

GALVESTON, Texas, Oct. 16, 2018 /PRNewswire/ — At the Gulf Coast Conference, Bruker announces the launch of the S2 POLAR™, a new multi-element benchtop analyzer based on polarized Energy Dispersive X-Ray Fluorescence (EDXRF). The S2 POLAR offers the same excellent analytical precision for quality control in the petrochemical industry, which is typically only achieved by more... Read more

Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH

– Acquisition expands Bruker’s Microbiology & Diagnostics business with profitable Molecular Diagnostics portfolio and substantial innovation pipeline – Novel Fluorocycler™ XT thermal cycler with high multiplexing real-time PCR capabilities enables proprietary, new Liquid Array™ assay format for affordable syndromic panels – Expanded FluoroType™ MTBDR 2.0 Liquid Array assay provides highly differentiated tuberculosis (TB) detection and... Read more

Bruker Partners with Greening Testing Laboratories to Provide Benchtop Brake Screening Services

Convenient and Cost-Effective Friction Materials Testing for the Automotive Industry SAN JOSE, CA and DETROIT, MI – October 15, 2018 – Bruker Nano Surfaces today announced a partnership with Greening Testing Laboratories, Inc. of Detroit to provide convenient and cost-effective benchtop friction test and particle screening capabilities to developers of friction materials. Under this partnership, Greening... Read more

Bruker Announces First Installation of High-field 9.4 Tesla Preclinical PET/MR System at the German Cancer Research Center

DUESSELDORF, Germany – October 14, 2018 – At the European Association of Nuclear Medicine Congress (EANM, eanm18.eanm.org ), Bruker  today announced the installation of a high-field 9.4 Tesla small animal preclinical magnetic resonance imaging (MRI) system with integrated, in-line PET (Positron Emission Tomography) at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. The new PET/MR system... Read more

Bruker Announces Breakthrough Proteomics and Lipidomics Workflow Advances for the timsTOF™ Pro at HUPO 2018

ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — At the 17th Annual World Congress of the Human Proteome Organization (www.hupo.org), Bruker announces next-generation workflows for the timsTOF Pro mass spectrometer. Introduced a year ago at the HUPO conference in Dublin, this revolutionary mass spectrometry platform is a new enabling technology for ultra-high sensitivity proteomics and large-cohort clinical... Read more

Bruker Launches the G4 ICARUSTM Series 2 Combustion Analyzer for High-Sensitivity Carbon and Sulfur Analysis

G4 ICARUS Series 2 – High-performance carbon and sulfur analyzer KARLSRUHE, Germany – September 27, 2018 – Bruker today announces the launch of the new G4 ICARUSTM Series 2, a versatile, high-sensitivity combustion analyzer for carbon and sulfur concentration measurements in inorganic samples. The G4 ICARUS Series 2extends Bruker’s line of compact, high-efficiency and low-maintenance combustion analyzers by introducing... Read more

Bruker Introduces New High Performance Preclinical PET/CT Si78 System

SEATTLE, Sept. 14, 2018 /PRNewswire/ — Bruker today announced the introduction of the new preclinical PET/CT Si78 scanner for whole-body molecular imaging at the World Molecular Imaging Congress (www.wmis.org/2018-wmic). It combines Bruker’s novel PET and outstanding micro-CT technologies in a single scanner operated by the multi-modality imaging software platform ParaVision™ 360. The PET/CT Si78 is addressing... Read more

Bruker Corporation to Present at the 16th Annual Morgan Stanley Global Healthcare Conference

BILLERICA, Mass., Sept. 7, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 16th Annual Morgan Stanley Global Healthcare Conference. Frank Laukien, President and Chief Executive Officer and Falko Busse, President of the Bruker BioSpin Group, will participate in a “fireside chat” Q&A session on behalf of the company on... Read more

Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH

— Bruker’s MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections — Acquisition to expand Bruker’s presence in attractive microbiology and virology infectious disease MDx markets, in support of Bruker’s portfolio transformation — Hain to add expertise in tuberculosis and mycobacteria... Read more

Bruker Announces Ultra-High Field NMR Orders from Major NMR Infrastructure Investment in the UK

BILLERICA, Mass., Aug. 6, 2018 /PRNewswire/ — Bruker today announced recent orders for its AVANCE® ultra-high field (UHF) nuclear magnetic resonance (NMR) spectroscopy systems from the United Kingdom.  The orders include two 1 GHz NMR systems for the University of Warwick and for the University of Birmingham.  The orders also include CryoProbes® and AVANCE NEO... Read more